Tirzepatide is a novel dual GIP/GLP-1 receptor agonist that has attracted significant research interest for its combined action on glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously. This dual-receptor engagement differentiates Tirzepatide from single-agonist compounds and has been studied for its pronounced effects on glycemic control, appetite regulation, and body weight reduction in metabolic research models. Preclinical and clinical studies examine its mechanisms of insulin potentiation, glucagon suppression, and energy expenditure modulation. A key compound in metabolic syndrome and obesity biology research. PeptideBull provides Tirzepatide at confirmed research-grade purity. Not intended for human or veterinary use.
Research Articles
Tirzepatide: The Dual GIP/GLP-1 Agonist Research
Discover Tirzepatide, a groundbreaking dual GIP and GLP-1 receptor agonist. This article delves into its research mechan...
GLP-1 Peptides: Semaglutide, Tirzepatide, Retatrutide Comparison
A comprehensive scientific comparison of GLP-1 peptides, including Semaglutide, Tirzepatide, and Retatrutide. Delve into...
GLP-1 Peptides: Semaglutide, Tirzepatide, Retatrutide Comparison
Discover the differences and similarities between Semaglutide, Tirzepatide, and Retatrutide. This article delves into th...